EAVI2020 EAVI2020 on Twitter EAVI2020 on LinkedIn

EAVI2020 Partner Focused Stories: University of Melbourne

Stephen Kent and Robin Shattock standing outside the entrance to St Mary's hospital

Prof Stephen Kent and Prof Robin Shattock outside the entrance to St Mary’s Hospital, Imperial College London

Established in 1853, the University of Melbourne (UOM) is an internationally recognised institution that makes distinctive contributions to society in research, learning and teaching and engagement. Ranked as one of the leading universities in the world, it is currently placed at number 1 in Australia and number 32 in the world (Times Higher Education World University Rankings 2018).

The EAVI2020 grant has given the Australian researchers involved in our EU funded project an opportunity to engage in a forum that enables free exchange of cutting edge ideas for vaccine design, provides a pipeline for the rapid pre-clinical and clearly phase clinical testing of their most promising constructs and allows access to expertise for the in-depth study of the immune responses these vaccines induce.

Prof. Stephen Kent, Principal Investigator for UOM, will be visiting several EAVI2020 Partners over the coming summer months. Most recently, he spent time with Prof. Robin Shattock of Imperial College London and will go on to visit Partners INSERM, CEA, AMC, UKER, UJF and KI. Stephen will also be attending the ‘One Health’ conference in Paris, the ‘IAS 2018’ conference in Amsterdam and an ‘NIH workshop on HIV antibody immunity’ in Washington DC, as well as visiting another HIV research group in Aarhus Denmark.

The Consortium as a whole enjoys and benefits greatly from its shared collaborative efforts, we look forward to the continued partnership with Stephen and his team.


CEA, Paris

Latest Posts

graphic illustration of red blood cells around a HIV virus cell
The Quest for an HIV…
June 24, 2022
World AIDS Vaccine Day…
May 18, 2022
Professor Gabriella Scarlatti hosting a panel, with Professor Robin Shattock and Dr Hans Langedijk in view
What’s next for…
April 28, 2022